PERILS AND DILEMMAS OF THE INDISCRIMINATE USE OF GLP‑1 AGONISTS FOR AESTHETIC WEIGHT LOSS. REMUNOM [Internet]. 2025 Sep. 15 [cited 2025 Sep. 20];17(1):1-9. Available from: https://remunom.ojsbr.com/multidisciplinar/article/view/4467